Physician profile
Benjamin Bernstein
NPI 1518915008
$3,442.43
in general payments reported to CMS, 2019-2025
22 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $447 · 2021: $166 · 2022: $218 · 2023: $456 · 2024: $1,078 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147 · Travel and Lodging: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.95 |
| Travel and Lodging | $700.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,056.01 | 2019-2020 | |
| Medtronic, INC. | $700.10 | 2024 | Interstim |
| Boston Scientific Corporation | $303.00 | 2019-2025 | Lithovue, Axonics |
| 180 Medical, INC. | $297.99 | 2021-2025 | Cure Ultra Catheter, Gentlecath, Cure Catheter |
| Procept Biorobotics Corporation | $166.25 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Myovant Sciences INC. | $138.06 | 2022 | |
| Janssen Biotech, INC. | $114.78 | 2022-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $76.47 | 2024-2025 | |
| Pfizer INC. | $75.76 | 2025 | |
| Intuitive Surgical, INC. | $65.10 | 2023 | Da Vinci Surgical System |
| Urogen Pharma, INC. | $58.25 | 2020-2021 | |
| Tolmar, INC. | $53.43 | 2024-2025 | Jatenzo, Eligard |
| Abbvie INC. | $50.37 | 2023-2024 | Lupron Depot, Botox |
| Coloplast Corp | $44.68 | 2023-2024 | Speedicath |
| Astrazeneca Pharmaceuticals Lp | $42.50 | 2023 | Lynparza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $40.46 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $38.93 | 2019-2023 | Myrbetriq |
| C. R. Bard, INC. & Subsidiaries | $30.30 | 2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $27.82 | 2025 | Gemtesa |
| Olympus America INC. | $26.04 | 2025 | Itind System |
| Teleflex LLC | $21.07 | 2024 | |
| Amgen INC. | $15.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.